Universe Pharmaceuticals INC Holds Shareholder Meeting
Ticker: UPC · Form: 6-K · Filed: Feb 20, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Uni Pharma held its shareholder meeting on Feb 19th after rescheduling from Feb 17th.
AI Summary
Universe Pharmaceuticals INC held an extraordinary general meeting of shareholders on February 19, 2025, which was a re-convening of a meeting originally scheduled for February 17, 2025. The meeting took place at 10:00 a.m. Beijing Time at the company's address in Ji'an, Jiangxi, China.
Why It Matters
This filing indicates a formal shareholder meeting occurred, which is a standard corporate governance event for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure about a shareholder meeting and does not contain significant financial or operational news.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Registrant
- February 19, 2025 (date) — Date of reconvened shareholder meeting
- February 17, 2025 (date) — Original date of shareholder meeting
- Ji'an, Jiangxi, China (location) — Company's principal executive offices
FAQ
What was the purpose of the February 2025 Extraordinary General Meeting of Shareholders?
The filing does not specify the purpose of the meeting, only that it was re-convened.
Why was the extraordinary general meeting of shareholders re-convened?
The filing states the meeting was re-convened but does not provide a reason for the re-convening.
What time was the February 2025 Extraordinary General Meeting held?
The meeting was held at 10:00 a.m. Beijing Time.
Where are Universe Pharmaceuticals INC's principal executive offices located?
The company's principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
Does Universe Pharmaceuticals INC file annual reports under Form 20-F or Form 40-F?
Universe Pharmaceuticals INC files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 20, 2025 regarding Universe Pharmaceuticals INC (UPC).